Lyon, France

Adocia


USPTO Granted Patents = 43

% Expired Patents = 32.6


Trademarks = 3

Forward Citations = 86

Loading Chart...
Loading Chart...

25 inventors (with patents filed for the assignee):

goldMedal Olivier Soula (24 out of 33 patents)

silverMedal Richard Charvet (20 out of 20 patents)

bronzeMedal Alexandre Geissler (13 out of 13 patents)

4 Remi Soula (13 out of 13 patents)

5 You-Ping Chan (9 out of 41 patents)

6 Gerard Soula (9 out of 61 patents)

7 Romain Noel (8 out of 8 patents)

8 Nicolas Laurent (8 out of 8 patents)

9 Gérard Soula (6 out of 14 patents)

10 Bertrand Alluis (5 out of 5 patents)

11 David Duracher (5 out of 5 patents)

12 Grégory Meiffren (4 out of 4 patents)

13 Walter Roger (3 out of 3 patents)

14 Emmanuel Dauty (3 out of 3 patents)

15 Ségolène Laage (3 out of 3 patents)


Core Competencies:
Hydrogels
Cell Therapy
Injectable Solutions
Amylin Analogues
Basal Insulin
Rapid-Acting Insulin
Human Glucagon
Co-Polyamino Acids
Oligosaccharides
Anionic Polysaccharides
Protein Solutions
Osteogenic Protein Complexes

43 patents:

Adocia is a clinical-stage biotechnology company specializing in the development of innovative formulations of therapeutic proteins and peptides for the treatment of diabetes and metabolic diseases. Their proprietary BioChaperone® technology platform allows for the optimization of drug pharmacokinetics, enhancing efficacy, and improving patient convenience and compliance.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

Adocia
43 Patents

#9 in Lyon

#541 in France

#15,987 in the World

Lyon, FR
Lyon, France
Forward Citations = 86

25 inventors:

Please report any incorrect information to [email protected]
Loading…